Cargando…
Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
BACKGROUND: Trastuzumab therapy given in combination with one of several chemotherapy regimens is currently considered the standard of care for the treatment of early-stage, human epidermal growth factor receptor-2 (HER2) -positive breast cancer. The treatment with trastuzumab is due to a significan...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Versita, Warsaw
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078028/ https://www.ncbi.nlm.nih.gov/pubmed/24991199 http://dx.doi.org/10.2478/raon-2013-0040 |